Severe fever with thrombocytopenia syndrome with re-infection in China: a case report

• Main Authors: Shou-Ming Lv, Chun Yuan, Lan Zhang, Yu-Na Wang, Zi-Niu Dai, Tong Yang, Ke Dai, Xiao-Ai Zhang, Qing-Bin Lu, Zhen-Dong Yang, Ning Cui, Hao Li, Wei Liu
• Format: Article
• Language: English
• Published: BMC 2021-06-01
• Series: Infectious Diseases of Poverty
• Subjects: Severe fever with thrombocytopenia syndrome; Re-infection; Tick-borne infectious disease
• Online Access: https://doi.org/10.1186/s40249-021-00877-6

Abstract Background Severe fever with thrombocytopenia syndrome (SFTS), an emerging tickborne infectious disease caused by a novel banyangvirus (SFTS virus, SFTSV), was endemic in several Asian countries with a high mortality up to 30%. Until recently, SFTSV-associated re-infection have not been reported and investigated. Case presentation A 42-year-old female patient was identified as a case of SFTS with re-infection, with two episodes of SFTSV infection on June 2018 and May 2020. The diagnosis of SFTS was confirmed by detection of SFTSV RNA in the blood samples using real-time reverse-transcription polymerase chain reaction and antibodies specific for SFTSV using enzyme linked immunosorbent assay. The changes of viremia and antibody response differed between the two episodes. Phylogenetic analysis showed the two viral genome sequences were in the same clade, but showing 0.6% dissimilarity of the nearly whole nucleotide sequence. Analysis of clinical data revealed that the second episode showed milder illness than that of the first episode. Conclusions Epidemiological and clinical findings, viral whole genomic sequences, and serological evidence, provided evidence for the re-infection of SFTSV rather than prolonged viral shedding or relapse of the original infection. The patients with re-infection of SFTSV may be at high odds of clinically inapparent or mildly symptomatic. More attention should be directed towards the long-term follow up of the recovered patients in the future, to explicitly acquire the decay profile of their immunity response. Graphic abstract